Jordi Magrane, PhD

Publications

4 grants

PI
Somatosensory pathology in a Friedreich's ataxia mouse model
Muscular Dystrophy Associations of America, Inc. · 2026–2029
MDAA 1459881
PI
Pre-clinical assessment of protein replacement therapy in the central nervous system of Friedreich's ataxia mouse models
Friedreich's Ataxia Research Alliance · 2025–2027
FARA 253852-02
PI
Postnatal development of the cerebellar circuitry in the KIKO mouse model of Friedreich's ataxia
Friedreich's Ataxia Research Alliance · 2024–2027
FARA 243859-03
PI
Selective frataxin deficiency in glial cells in vivo in novel mouse models of Friedreich's ataxia
National Ataxia Foundation · 2024–2026
NAF 235214-01

Completed grants (7)

PI
Cell & non-cell autonomous effects of frataxin deficiency in FA pathophysiology
Muscular Dystrophy Associations of America, Inc. · 2019–2025
MDAA 629299
PI
Assessment of early somatosensory impairment in the KIKO mouse model of Friedreich's ataxia
Friedreich's Ataxia Research Alliance · 2021–2025
FARA 211719-02
Sub-PI
Modeling Friedreich Ataxia in human PSC-derived sensory neuron subtypes
Friedreich's Ataxia Research Alliance · 2018–2021 · via Columbia University
FARA CU17-1234
PI
Functional Analysis of Primary Sensory Neurons and (Proprio) Sensory Pathology in Friedreich's Ataxia
Friedreich's Ataxia Research Alliance · 2017–2021
FARA 170266-02
Co-I
Mitochondria Quality Control In SOD1-ALS
National Institute of Neurological Disorders and Stroke · 2009–2020· 2 renewals
R01NS062055-10
Sub-PI
Evaluation of CAT-4001 in Frataxin-Deficient Mouse Models and DRG Neurons to Enable its Therapeutic Development to Treat Friedrich's Ataxia
Friedreich's Ataxia Research Alliance · 2015–2019 · via Catabasis Pharmaceuticals Inc
CP 16101762-03
PI
A Novel Mouse Model to Specifically Alter Mitochondrial Distribution in vivo
National Institute of Neurological Disorders and Stroke · 2013–2016
R03NS082716-02EWO